Expression of HOXA9 mRNA and its clinical significance in primary hepatocarcinoma

向志钢,杨竹林,邓星辉,苗雄鹰,胡继雄,黄生福
DOI: https://doi.org/10.3969/j.issn.1005-8982.2004.01.007
2004-01-01
Abstract:Objective: To study the expression of HOXA9 mRNA and its clinical significance in liver cancer tissues, paracancerous liver tissues and non -cancer liver tissues. Methods: HOXA9 mRNA was detected by in situ hybridization technique. The specimens were fixed by 10% neutral formalin and then routinely made into paraffin - embedded sections. Results: Clinical analysis showed significantly lower values of AFP, AFU, Glo and PAB and positiverate of SHCSP in postoperative patients. The scoring mean of HOXA9 nRNA expression in the cancer tissues ( 1.94 +i. 69) was significantly lower than that in the non - cancer liver tissues (3.17 + 1. 70). There was no significant differenee in scoring means of HOXA9 mRNA expression between the paracancerous tissues (2.54 ± 1.20) and non -cancerliver tissues. There was no significant difference in positive rate of HOXA9 mRNA expression among the cancer tissues,the paracancerous liver tissues and the non - cancer liver tissues (54.84%, 76.92% and 83.33% respectively). Apart from the scoring mean of HOXA9 mRNA expression being significantly lower in the HCC (1.81 ± 1.78) than in MHC (2.75 ± 0.50), no correlations were revealed between the positive rate, the scoring mean of HOXA9 mRNA andthe other clinical features. Conclusion: This study showed that the HOXA9 mRNA might be related to the carcinogenesis of hepatocarcinoma. The assays of HOXA9 mRNA expression might have important clinical values in theearly discovery and diagnosis of primary hepatocarcinoma.
What problem does this paper attempt to address?